Common Stock, Shares, Outstanding of NAVIDEA BIOPHARMACEUTICALS, INC. from 31 Dec 2010 to 30 Sep 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NAVIDEA BIOPHARMACEUTICALS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2023.
  • NAVIDEA BIOPHARMACEUTICALS, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2023 was 100,084,385, a 211% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 100,084,385 +67,933,467 +211% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 96,149,385 +65,784,593 +217% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 32,851,252 +2,493,960 +8.2% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 32,687,666 +2,407,744 +8% 31 Dec 2022 10-Q 14 Nov 2023 2023 Q3
Q3 2022 32,150,918 +1,987,673 +6.6% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 30,364,792 +219,074 +0.73% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 30,357,292 +1,651,105 +5.8% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 30,279,922 +3,130,231 +12% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 30,163,245 +3,789,337 +14% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 30,145,718 +5,597,757 +23% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 28,706,187 +7,511,939 +35% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 27,149,691 +7,914,731 +41% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 26,373,908 +8,314,502 +46% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 24,547,961 +6,488,555 +36% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 21,194,248 +11,141,856 +111% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 19,234,960 +9,215,425 +92% 31 Dec 2019 10-K 26 Mar 2021 2020 FY
Q3 2019 18,059,406 -163,831,294 -90% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 18,059,406 -145,560,684 -89% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 10,052,392 -152,907,339 -94% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 10,019,535 -152,187,111 -94% 31 Dec 2018 10-K 18 Mar 2020 2019 FY
Q3 2018 181,890,700 +19,684,054 +12% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 163,620,090 +1,413,444 +0.87% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 162,959,731 +1,061,393 +0.66% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 162,206,646 +6,443,917 +4.1% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q3 2017 162,206,646 +6,455,330 +4.1% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 162,206,646 +6,565,912 +4.2% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 161,898,338 +6,392,755 +4.1% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 155,762,729 +113,064 +0.07% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 155,751,316 +5,047,831 +3.4% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 155,640,734 +4,929,141 +3.3% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 155,505,583 +4,894,723 +3.2% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 155,649,665 +5,449,406 +3.6% 31 Dec 2015 8-K 15 Dec 2017 2016 FY
Q3 2015 150,703,485 -31,897 -0.02% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 150,711,593 +75,700 +0.05% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 150,610,860 +772,941 +0.52% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 150,200,259 +14,280,836 +11% 31 Dec 2014 10-K 23 Mar 2016 2015 FY
Q3 2014 150,735,382 +16,389,899 +12% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 150,635,893 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 149,837,919 +32,347,810 +28% 31 Mar 2014 10-Q 09 May 2014 2014 Q1
Q4 2013 135,919,423 +22,900,651 +20% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 134,345,483 +26,974,851 +25% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q1 2013 117,490,109 +21,317,779 +22% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 113,018,772 +17,619,811 +18% 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q3 2012 107,370,632 +12,260,105 +13% 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 96,809,622 +2,271,686 +2.4% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 96,172,330 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 95,398,961 +9,079,048 +11% 31 Dec 2011 10-K/A 21 Mar 2013 2012 FY
Q3 2011 95,110,527 30 Sep 2011 10-Q 13 Nov 2012 2012 Q3
Q2 2011 94,537,936 30 Jun 2011 10-Q 09 Aug 2012 2012 Q2
Q4 2010 86,319,913 31 Dec 2010 10-K 07 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.